ABSTRACT
Introduction: Neuromuscular blockers like Rocuroniumbromide can impair respiratory functions during generalanaesthesia. Therefore aim of present study was to find outthe biochemical changes of Rocuronium bromide and othermuscle relaxant in cardiac surgery.Material and Methods: Present study was carried out onsixty (60) patients of different age groups from both sexesscheduled for various cardiac surgical procedures at L.P.S.Institute of Cardiology, GSVM medical college Kanpurduring the period of August 1998 to August 1999. Patientswere classified in 3 equal groups. Muscle relaxants were givenaccording to the group and biochemical parameters like PCo2,PO2, pH etc. were recorded carefully at the interval of two,five and ten minutes.Results: No statistically significant changes were observed inPCo2, pH, Na+, K+ at 2 minutes, 5 minutes and 10 minutes afterthe administration of all three drugs (P >0.05) compared withcontrol values. Statistically Significant changes in PO2 andO2 saturation was observed at 2 minutes, 5 minutes and 10minutes after the administration of Pancuronium (P <0.05).Conclusion: Rocuronium bromide is safer in cardiac surgeryas compared to other muscle relaxants.
ABSTRACT
Long QT Syndrome (LQTS), a disorder of the cardiac repolarization process with prolongation of the QT interval (QTc ≥0.46 seconds), is an ion-channelopathy. Mutations in either KCNQ1 or KCNE1 genes are susceptible to LQTS. Hence, screening of KCNQ1 and KCNE1 genes is taken up to evaluate the genetic correlation of these genes in Long QT patients of Indian origin. A total of 33 Long QT Syndrome patients and 100 healthy subjects were enrolled for the present study. PCR-SSCP protocol was utilised for screening of KCNQ1 and KCNE1 genes followed by In-silico and statistical analysis. The clinical profile of the Long QT syndrome patients in our study revealed a higher percentage of females with the mean age also being higher in females when compared to males. The two variations (S546S and IVS13+36A>G) in KCNQ1 and the S38G polymorphism in KCNE1 gene were identified and their association with Long QT syndrome is being reported for the first time in Indian population. S546S is located in the KCNQ1 C terminus close to this domain and IVS13+36A>G is located in the intronic region in close proximity to the coding region for C-terminal domain; these may therefore affect the functional protein through non-assembly. S38G leads to a substitution of serine to glycine at 38th amino acid position (S38G) in the transmembrane domain of KCNE1. Our study reports compound heterozygosity/genetic compound ofS546S and IVS13+36A>G of KCNQ1 gene. Haplotype frequencies and linkage disequilibrium analysis revealed a significant association between the three biomarkers. Compound heterozygosity of the polymorphisms influence downstream signalling and KCNQ1- KCNE1 interactions.